We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

130 hedge funds and large institutions have $2.08B invested in Karuna Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 61 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

388% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 8

177% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 22

73% more capital invested

Capital invested by funds: $1.2B → $2.08B (+$880M)

31% more funds holding

Funds holding: 99 → 130 (+31)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

72% less call options, than puts

Call options by funds: $3.02M | Put options by funds: $10.9M

Holders
130
Holders Change
+31
Holders Change %
+31.31%
% of All Funds
2.67%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
39
Increased
61
Reduced
22
Closed
8
Calls
$3.02M
Puts
$10.9M
Net Calls
-$7.84M
Net Calls Change
-$3.76M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$51M
2
State Street
State Street
Massachusetts
+$46.4M
3
BlackRock
BlackRock
New York
+$27.7M
4
Fidelity International
Fidelity International
Bermuda
+$24.2M
5
CTA
Carillon Tower Advisers
Florida
+$16M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$39.4M
2
VC
Vivo Capital
California
-$16.1M
3
PHS
PFM Health Sciences
California
-$12.8M
4
LCM
Laurion Capital Management
New York
-$8.12M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
51
First Trust Advisors
Illinois
$3.44M +$101K +1,160 +4%
MAP
52
Moody Aldrich Partners
Massachusetts
$3.38M +$387K +4,454 +17%
TCM
53
Tekla Capital Management
Massachusetts
$3.33M +$2.6M +29,873 New
Bank of America
54
Bank of America
North Carolina
$3.2M +$856K +9,843 +52%
TD Asset Management
55
TD Asset Management
Ontario, Canada
$3M +$52.2K +600 +2%
Swiss National Bank
56
Swiss National Bank
Switzerland
$2.92M +$2.28M +26,200 New
KWILP
57
Kiwi Wealth Investments Limited Partnership
New Zealand
$2.89M +$198K +2,277 +10%
EI
58
EAM Investors
California
$2.62M -$1.48M -17,053 -42%
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$2.61M +$646K +7,426 +47%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$2.54M +$771K +8,870 +64%
Susquehanna International Group
61
Susquehanna International Group
Pennsylvania
$2.48M +$687K +7,902 +55%
Citigroup
62
Citigroup
New York
$2.37M +$927K +10,657 +101%
State of Wisconsin Investment Board
63
State of Wisconsin Investment Board
Wisconsin
$1.93M +$86.9K +1,000 +6%
Wells Fargo
64
Wells Fargo
California
$1.66M +$397K +4,571 +44%
New York State Common Retirement Fund
65
New York State Common Retirement Fund
New York
$1.58M +$869K +10,000 +238%
EGI
66
EAM Global Investors
California
$1.47M -$1.21M -13,910 -51%
SFI
67
Susquehanna Fundamental Investments
Pennsylvania
$1.36M +$1.06M +12,200 New
Millennium Management
68
Millennium Management
New York
$1.29M +$1.01M +11,597 New
N
69
Nuveen
North Carolina
$1.28M +$2.38M +27,392 +61%
Two Sigma Investments
70
Two Sigma Investments
New York
$1.21M +$943K +10,847 New
SEI Investments
71
SEI Investments
Pennsylvania
$1.17M -$23.4K -269 -2%
PPA
72
Parametric Portfolio Associates
Washington
$1.13M -$175K -2,016 -17%
AIG
73
American International Group
New York
$1.06M +$284K +3,270 +53%
Barclays
74
Barclays
United Kingdom
$1.03M +$478K +5,496 +145%
DCM
75
DAFNA Capital Management
California
$1.03M +$261K +3,000 +48%
1 2
3
4 5

KRTX Hedge Fund Activity: Q2 2020 in Review

130 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q2 2020, worth a combined $2.08B — up 73% from $1.2B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new KRTX positions and 8 closed out — a net gain of 31 holders — while 61 added to existing stakes and 22 trimmed.

The largest buyer was Vanguard Group, adding an estimated $51M. The largest seller was T. Rowe Price Associates, cutting an estimated $39.4M.

  • 130 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q2 2020, up from 99 in Q1 2020.
  • Funds reported $2.08B of Karuna Therapeutics, Inc. Common Stock stock for Q2 2020, up 73% quarter-over-quarter.
  • 39 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q2 2020 and 8 closed out, a net change of +31 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock buyer in Q2 2020 was Vanguard Group, an estimated $51M added.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q2 2020 was T. Rowe Price Associates, an estimated $39.4M sold.

Based on aggregated 13F filings for Q2 2020.